Financing led by new investor TCGX, alongside Goldman Sachs Alternatives, Avoro Ventures and venBio·        Funding will support and accelerate development of next-generation multivalent respiratory ...

Recommendation based on a phase 3 study showing a significantly greater proportion of children on Dupixent achieved histological remission, compared to placebo, consistent with improvements seen in ...

RIM-TD open-label extension (OLE) study showed long-term improvement of Tardive Dyskinesia (TD) symptoms from treatment with deutetrabenazine over three years in European patients1 TD is an ...

Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative ...

Kate Shaw, founder and CEO of Innovative Trials, a global clinical trial patient recruitment and retention company, has been crowned a top ‘Woman in Pharma’ at the Pharma Industry Awards UK. She was ...

Approval based on positive results from the IMROZ phase 3 study demonstrating Sarclisa in combination with bortezomib, lenalidomide, and dexamethasone (VRd) significantly improved progression-free ...

Biocomposites-sponsored symposium to focus on how to improve outcomes in complex periprosthetic joint infection (PJI) cases, with insights from leading surgeons Abstract by Biocomposites’ researchers ...

New indication supported by the MANDARA trial which showed nearly 60% of patients achieved remission and 41% of patients fully stopped taking oral corticosteroids AstraZeneca’s Fasenra (benralizumab) ...

The Association of the British Pharmaceutical Industry (ABPI) and the Prescription Medicines Code of Practice Authority (PMCPA) have published an updated Code of Practice for the pharmaceutical ...

Integration of Nova’s BioProfile® FLEX2 will enable automated cell culture analyses for process development through commercial manufacturing with Quantum FlexLakewood, Colorado, U.S., September 23, ...

Chancellor Rachel Reeves addressed the Labour Party Conference today, setting out Labour’s plans for economic stability and growth. Responding to her words, ABPI Executive Director of Corporate ...

Extension of indication for Buccolam 10 mg to now include treatment of adults as well as childrenPaves way for the extension of well-established and pan-European market-leading brand to include the ...